HLA-B and HIV infectious disease: Our observation probably reflects the fact that the immunological advantage of HLA-B*57 seen in untreated HIV infection is lost when HIV replication falls below detectable levels, while residual HIV replication may still cause enhanced immune activation and a immune dysregulation syndrome [16–18].